NEW YORK (GenomeWeb News) – Less than a year after surpassing 300 employees, the Seattle Biomedical Research Institute will be "shooting for 400" in the new year by expanding its work in immunology and systems biology, as well as continuing its research programs in malaria, HIV, tuberculosis, and neglected trypanosomatid diseases, President and Director Ken Stuart told GenomeWeb Daily News this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.